Merit medical's wrapsody wave trial exceeds performance goals for arteriovenous graft (avg) patients

Wrapsody achieves 82% target lesion primary patency at six months in the single-arm cohort of the us pivotal trial wrapsody achieves 82% target lesion primary patency at six months in the single-arm cohort of the us pivotal trial
MMSI Ratings Summary
MMSI Quant Ranking